Table 1 Patient demographics and disease characteristics.
Total (N = 51) | |
|---|---|
Median age (range), years | 61 (38–81) |
Sex, n (%) | |
Male | 22 (43.1) |
Female | 29 (56.9) |
Race, n (%) | |
White | 45 (88.2) |
Black or African American | 3 (5.9) |
Other | 1 (2.0) |
Missing | 2 (3.9) |
ECOG PS, n (%) | |
0 | 15 (29.4) |
1 | 35 (68.6) |
2 | 1 (2.0)a |
Number of prior systemic therapies | |
Median (range) | 3 (1–9) |
1 line, n (%) | 7 (13.7) |
2–3 lines, n (%) | 25 (49.0) |
>3 lines, n (%) | 19 (37.3) |
Best overall response to most recent prior regimen, n (%) | |
CR | 1 (2.0) |
PR | 6 (11.8) |
Non-CR/non-PD | 2 (3.9) |
SD | 16 (31.4) |
PD | 18 (35.3) |
NE | 1 (2.0) |
NA | 6 (11.8) |
Missing | 1 (2.0) |
Primary diagnosis, n (%) | |
Breast | 10 (19.6) |
Colon | 3 (5.9) |
Lung | 15 (29.4) |
NSCLC | 7 (13.7) |
SCLC | 7 (13.7) |
Mesothelioma | 1 (2.0) |
Ovary | 2 (3.9) |
Prostate | 6 (11.8) |
Other | 15 (29.4) |
